Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease
Tumor-induced osteomalacia (TIO) is a rare acquired paraneoplastic disorder and fibroblast growth factor 23 (FGF23) plays a key role in its pathogenesis. This study was conducted to describe a novel FGF23 detecting procedure and describe clinical features of the disease. Fourteen TIO cases were retr...
Main Authors: | Fangke Hu, Chengying Jiang, Qiang Zhang, Huaiyin Shi, Lixin Wei, Yan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2016/3176978 |
Similar Items
-
Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)
by: Yuka Kinoshita, et al.
Published: (2019-06-01) -
Fibroblast Growth Factor 23-Producing Phosphaturic Mesenchymal Tumor with Extraordinary Morphology Causing Oncogenic Osteomalacia
by: Cornelia Then, et al.
Published: (2020-01-01) -
Selective blood sampling for FGF-23 in tumor-induced osteomalacia
by: Hans-Christof Schober, et al.
Published: (2017-10-01) -
Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia
by: Seiji Fukumoto
Published: (2014-06-01) -
Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
by: S. S. Rodionova, et al.
Published: (2019-12-01)